STAT+: Pharmalittle: FDA commish calls U.S. drug prices ‘too high’; FDA staff says Eisai and Biogen’s Alzheimer’s drug has benefits
STAT
JUNE 8, 2023
As always, you are invited to join us. Food and Drug Administration Commissioner Robert Califf told a crowd of biotech leaders that drug costs needed fixing , STAT reports. “We Nonetheless, there is much to do. So as usual, we are firing up the trusty coffee kettle to brew a cup or three of stimulation.
Let's personalize your content